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The syndrome of hyperandrogenism, insulin resistance, and acanthosis nigricans (HAIRAN) is a subphenotype of the polycystic ovary syndrome. It is one of the most common
causes of menstrual problems, hyperandrogenic symptoms, and insulin resistance
among young women. Review of clinical data in an outpatient adolescent clinic showed
that of the 1,002 young women (ages 10–21 years) attending the clinic over a 2-year
period, 50 (5%) were diagnosed with HAIR-AN syndrome. Mean age of the patients was
15.5, initial mean weight at diagnosis was 94.5 kg, and the mean BMI was 33.33 kg/m2.
Patients were treated with a weight-stabilization and -reduction program, oral
contraceptive pills, and in most cases metformin. Of the patients, 80% were compliant
with the follow-up and treatment regimen, 60% maintained or reduced their weight, 95%
had regular menstrual cycles, and in most patients, the acne and/or hirsutism were the
same or better than at the start of treatment. We conclude that HAIR-AN syndrome is a
common disease in young women and multifaceted, aggressive treatment appears to be
effective in reducing the severity of symptoms and preventing further consequences.
KEYWORDS: adolescent medicine, hyperandrogenism, insulin resistance, acanthosis
nigricans, metformin, HAIR-AN syndrome, polycystic ovary syndrome, United States
DOMAINS: child health and human development, medical care, behavioral psychology, clinical
psychology, psychiatry, nursing, oncology

INTRODUCTION
The syndrome of hyperandrogenism, insulin resistance, and acanthosis nigricans (HAIR-AN) has been
known for almost 30 years[1,2,3,4]. The primary abnormality in these patients is thought to be insulin
resistance with elevated insulin levels[1,2]. This syndrome is a unique subphenotype of the polycystic
ovary syndrome and is seen in almost 5% of all females with hyperandrogenism[2,5]. Obesity, acne,
hirsutism, and acanthosis nigricans usually appear on the afflicted adolescent around puberty[6].
Hirsutism is defined as the growth of pigmented hair on the chest, back, and lower abdomen.
Acanthosis nigricans describes darkly pigmented, velvety areas of the skin. This manifestation of the
syndrome is associated with insulin resistance and decreased insulin sensitivity[7]. It is still not
*Corresponding author.
©2004 with author.

507

Omar et al.: Transdermal Contraception

TheScientificWorldJOURNAL (2004) 4, 507–511

completely known how insulin resistance occurs, however, defects and genetic receptors are thought to be
responsible in most patients[1,3,4]. When insulin levels are markedly elevated over time, they tend to
directly stimulate the overproduction of androgens in the ovaries[3,8]. It is thought that high insulin levels
cross-react with receptors for insulin-like growth factors leading to increased ovarian androgen
production[2,3,8]. Approximately 5% of women with hyperandrogenism and insulin resistance also tend
to have acanthosis nigricans[9,10]. Patients with HAIR-AN syndrome may present with amenorrhea and
signs of verilization[2,4]. They may also have increased levels of insulin, testosterone, and
androstenedione levels with normal andrenal function[3]. Adolescents with HAIR-AN syndrome usually
present with normal levels of luteinizing hormone (LH) and follicle-stimulating hormone (FHS)[3],
although the ratio of LH to FHS is usually more than one. There are no specific protocols for treatment of
this syndrome. Current management usually involves oral contraceptive pills with or without an
antiandrogen. Oral contraceptives may suppress the hypothalamic-pituitary-ovarian axis which would
lower ovarian steroid production[3].
Metformin is an insulin-sensitizing drug that has also been used in the treatment of HAIR-AN
syndrome. Few studies test its use in adolescents, but in small trials it appears to reduce weight gain and
regulate menstrual cycles. The effect of metformin on hirsutism has not been adequately studied[11]. The
reduction of insulin resistance by metformin could reduce the appearance of acanthosis nigricans on the
adolescent[12]. Previous studies have shown that metformin reduces the body mass index (BMI) of
HAIR-AN patients and also helps regulate the menstrual cycle[13]. Use of cosmetic methods such as laser
hair removal can also be utilized to reduce the severity of existing hirsutism[11]. Weight loss is also an
effective way to reduce the manifestations of HAIR-AN syndrome and also reduce the risk for other
diseases including diabetes and heart disease. A lower-calorie diet rich in fiber and protein can aid in
healthy weight loss for the obese adolescent[6]. It is also recommended that physicians council the
adolescent about the importance of exercise and assist in the formation of an exercise program tailored to
the individual patient.
Beyond physical treatment of HAIR-AN syndrome, physicians should also be observant of the mental
state of the patient. Most adolescent females are concerned with their body image and are sensitive to the
phenotypic manifestations of the syndrome[11]. A short evaluation of the patient’s concerns and emotions
associated with the diagnosis of HAIR-AN syndrome can alert physicians to any problems. Reassurance
and thorough explanations of the treatment can comfort and encourage the patient.
In this study, we reviewed clinical data from patients attending the Adolescent Medicine Clinic at the
University Based Health Center to investigate the occurrence.

METHODS
Retrospective review of medical records attending the Adolescent Medicine Clinic at the University
Based Health Center in a medium-sized city was performed to assess the occurrence, clinical profiles, and
management issues of patients with HAIR-AN syndrome. The study was approved with an exemption
protocol from the Institutional Review Board at the University of Kentucky, Lexington.

RESULTS
In the period between January 2000 and December 2002, a total of 1,002 young women between the ages
of 10 and 21 years attended the Adolescent Medicine Clinic at the University Based Health Center. This
number included all visits regardless of the reason for attending the clinic, including health maintenance,
acute care, or family planning. A total of 136 patients (13.6%) presented with complaints of irregular
menstrual periods; 50 patients (5% of the total and 36.8% of those with irregular periods) were diagnosed
with HAIR-IN syndrome. Patients were diagnosed with HAIR-AN syndrome if they had clinical
characteristics indicating hyperandrogenism, insulin resistance, and acanthosis nigricans[14].
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Demographic characteristics of the patients are shown in Table 1. All 50 patients had laboratory evidence
of insulin resistance (elevated insulin level) and most patients had one or more laboratory values
indicative of hyperandrogenism[1,2,3,4,5,6,7,14]; 74% of the patients had at least one comorbidity
(Tables 1 and 2).
TABLE 1
Demographic and Clinical Profiles of Patients
Age (Mean + SD}
Race
Menarche
Initial weight
Initial BMI
Previous pregnancy
Current sexual activity
Comorbidity
Insurance

15.5 ± 2.7 Years, 10–19
20 (40%) W, 27 (54%) B, 3 (6%) Other
10.8 ± 1.3 Years of age
94.5 ± kg (208.9 ± 44.6 lb)
2
33.1 ± 4.1 kg/m
3 (6%) Yes, 47 (94%) No
15 (30%) Yes, 35 (70%) No
37 (74%) Yes, 13 (26%) No
28 (56%) MC, 18 (36%) Private, 4(8%) None

Age range
given as 1021
elsewhere.

TABLE 2
Most Common Comorbidity
Depression
Bipolar disorder
Learning disability
Recurrent headaches
Allergies
Hypertension
GERD
Diabetes (Type II)

12 (24%)
2 (4%)
1 (2%)
17 (34%)
22 (44%)
4 (8%)
4 (8%)
8 (16%)

Once the diagnosis was made, patients were treated by a team consisting of an adolescent medicine
physician, nutritionist, social worker, and psychologist. Treatment included nutrition changes and a
physical activity regimen with the goal of maintaining, then reducing, body weight. Patients were also
started on periodic psychology counseling to improve self-esteem and to address any mental health issues.
All patients were started on monophasic, low androgenic, oral contraceptive pills, usually
norgestimate/ethinyl estradiol or drospirenone/ethinyl estradiol. Forty patients (80%) who had fasting
glucose to insulin ratio of less than five were also started on metformin (Bristol-Myers Squibb, Princeton,
NJ) or generic equivalent. Patients were usually started on a dose of 500 mg once a day for 1 week, then
the dose was gradually increased to a maximum of 100 mg twice a day depending on tolerance of the
patient to the medication. All patients had a metabolic screen and liver function test performed prior to
starting metformin and every 6 months thereafter.
Evaluation of patients every 3 months showed that 80% of the patients were compliant with all
aspects of treatment throughout the follow-up period and 20% of the patients had no compliance issues
either with the physical activity/nutrition plan or with taking their oral contraceptive pills. Interestingly,
all patients were compliant with the psychological counseling for the allotted 6 months of treatment. All
patients that were compliant with oral contraceptive pills had regular menstrual periods following
treatment and their acne and/or hirsutism improved or were unchanged after treatment, 20% of the
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patients had improvement in their acanthosis nigricans, while the others were unchanged. Of the patients
on metformin, 40% reported nausea, but no other side effects were reported and none had a problem with
liver function at follow-up. Only 1 patient out of the 40 (2.5%) using metformin discontinued use because
of nausea.

DISCUSSION
Most adolescent females are usually concerned about their body image and are very sensitive to any
changes that may interfere with their appearance[11]. The symptoms of HAIR-AN syndrome do exactly
that, by increasing the severity of acne, by inducing hirsutism and the appearance of acanthosis nigricans,
in addition to obesity[2,3,4,5,6]. In addition to the appearance issues there are also significant medical
consequences such as irregular periods, infertility, and type II diabetes[2,3,4,5,6]. Early detection,
diagnosis, and treatment of HAIR-AN syndrome may reduce the symptoms and improve the quality of
life of these young women. Based on the results of this study, HAIR-AN syndrome appears to be a fairly
common disorder in adolescents with 5% of the clinic female adolescent population suffering from the
disease. This number is somewhat higher than what is reported in other studies[9,10]. In part, this may be
due to the fact that our clinic is a tertiary care center and attended by patients with more morbidity
referred by their primary care providers. Nevertheless, this syndrome constitutes significant problems for
young women.
In this study, 30% of the patients with HAIR-AN syndrome also had a mental health comorbidity,
most frequently depression, in 24% of the patients (Table 2); 70% of the patients in this study were not
sexually active, which is different than their peer groups in our area, where 68% of the 16 year olds have
had at least one sexual experience (unpublished observation). In general, adolescents are notoriously
noncompliant with long-term treatment. In this study, however, 80% of the patients were compliant with
treatment, which may be due to the multidisciplinary approach to the patient in our clinic in addition to
the desire to improve their appearance and self-esteem.
The finding that metformin was well tolerated in this patient population may help future long-term
prospective studies on the subject. In most patients, there was significant success of treatment both in
terms of appearance and actual improvement in regulating their menstrual periods, improving their BMI,
and preventing the development of type II diabetes and other severe medical consequences.
Our study is limited by the retrospective nature and the relatively small number of participants.

CONCLUSION
HAIR-AN syndrome is a common multisystem disorder in the adolescent age group, which is associated
with significant morbidity and self-esteem issues. Early detection, diagnosis, and treatment can help
reduce further morbidity, improve self-esteem, and have a positive impact on the quality of life of these
patients.

REFERENCES
1.
2.
3.
4.
5.

Barbieri, R.L. (1990) Hyperandrogenic disorders. Clin. Obstet. Gynecol. 33, 640–654.
Barbieri, R.L., Smith, S., and Ryan, K.J. (1988) The role of hyperinsulinism in the pathogesis of ovarian
hyperandrogenism. Fertil. Steril. 50, 197–212.
Barbieri, R.L. and Ryan, K.J. (1983) Hyperandrogenism, insulin resistance and acanthosis nigricans syndrome: a
common endocrinopathy with distinct pathophysiologic features. Am. J. Obstet. Gynecol. 147, 90–101.
Kahn, C.R., Flier, J.S., and Bar, R.S. (1976) The syndromes of insulin resistance and acanthosis nigricans. N. Engl. J.
Med. 294, 739–745.
Barbieri, R.L. and Hornstein, M.D. (1988) Hyperinsulinemia and ovarian hyperandrogenism. Endocrinol. Metab.
Clin. North Am. 17, 685–703.

510

Omar et al.: Transdermal Contraception

6.
7.
8.
9.

10.

11.
12.
13.
14.

TheScientificWorldJOURNAL (2004) 4, 507–511

Schroeder, B., Ding, X., and Pfaff-Amesse, T. (2002) From HAIR-An to eternity. J. Pediatr. Adolesc. Gynecol. 15,
235–240.
Zemtsov, A. and Wilson, L. (1997) Successful treatment of hirsutism in HAIR-AN syndrome using flutamide,
spironolactone, and birth control therapy. Arch. Dermatol. 133, 431–432.
Nestler, J.E. and Strauss, J.F., III (1991) Insulin as an effector of human ovarian and adrenal steroid metabolism.
Endocrinol. Metab. Clin. North Am. 20, 807–823.
Dunaif, A., Green, G., Phelps, R.G., Lobwohl, M., Futterweit, W., and Lewy, L. (1991) Acanthosis nigricans, insulin
action, and hyperandrogenism; clinical, histological, and biochemical findings. J. Clin. Endocrinol. Metab. 73, 590–
595.
Dunaif, A., Hoffman, A.R., Scully, R.E., Flier, J.S., Longcope, C., Levy, L.J., and Crowley, W.F., Jr. (1985) Clinical,
biochemical and ovarian morphologic features in women with acanthosis nigricans and masculization. Obstet.
Gynecol. 66, 545–552.
Pfeifer, S.M. and Dayal, M. (2003) Treatment of the adolescent patient with polycystic ovary syndrome. Obstet.
Gynecol. Clin. North Am. 30, 337–352.
Pfeifer, S.L.E., Wilson, R.M., and Gawkrodger, D.J. (1999) Clearance of acanthosis nigricans associated with the
HAIR-AN syndrome after partial pancreatectomy. Postgrad. Med. J. 75, 421–423.
Haas, D.A., Carr, B.R., and Attia, G.R. (2003) Effects of metformin on body mass index, menstrual cyclicity, and
ovulation induction in women with polycystic ovary syndrome. Fertil. Steril. 79, 469–481.
Elmer, K.B. (2001) HAIR-AN syndrome: a multisystem challenge. (hyperandrogenism, insulin resistance, and
acanthosis nigricans). Am. Fam. Physician 63(12), 2385–2391.

This article should be referenced as follows:
Omar, H.A., Logsdon, S., and Richards, J. (2004) Clinical profiles, occurrence, and management of adolescent patients with
HAIR-AN syndrome. TheScientificWorldJOURNAL 4, 507–511.
Handling Editor:
Joav Merrick, Principal Editor for Child Health and Human Development — a domain of TheScientificWorldJOURNAL.

BIOSKETCHES
Hatim A Omar, MD, Professor of Pediatrics, Obstetrics and Gynecology and Director of the Section of
Adolescent Medicine, Department of Pediatrics, University of Kentucky, Lexington. Dr. Omar has
completed residency training in Obstetrics and Gynecology as well as Pediatrics. He has also completed
fellowships in Vascular Physiology and Adolescent Medicine. He is the recipient of the Commonwealth
of Kentucky Governor’s Award for Community Service and Volunteerism and is well known
internationally as an authority in Adolescent Medicine and Pediatric and Adolescent Gynecology. E-mail:
haomar2@uky.edu
Stephanie Logsdon, is an undergraduate student at the University of Kentucky, majoring in biology. She
has worked during her summer research project with the Section of Adolescent Medicine, Department of
Pediatrics, University of Kentucky, Lexington.
Jessica Richards, RN, Section of Adolescent Medicine, Department of Pediatrics, University of
Kentucky, Lexington. She is very active in research concerning adolescents and teen mothers.

511

International Journal of

Peptides

BioMed
Research International
Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Advances in

Stem Cells
International
Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Virolog y
Hindawi Publishing Corporation
http://www.hindawi.com

International Journal of

Genomics

Volume 2014

Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Journal of

Nucleic Acids

Zoology

International Journal of

Hindawi Publishing Corporation
http://www.hindawi.com

Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Volume 2014

Submit your manuscripts at
http://www.hindawi.com
The Scientific
World Journal

Journal of

Signal Transduction
Hindawi Publishing Corporation
http://www.hindawi.com

Genetics
Research International
Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Anatomy
Research International
Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Enzyme
Research

Archaea
Hindawi Publishing Corporation
http://www.hindawi.com

Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Volume 2014

Hindawi Publishing Corporation
http://www.hindawi.com

Biochemistry
Research International

International Journal of

Microbiology
Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

International Journal of

Evolutionary Biology
Volume 2014

Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Molecular Biology
International
Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Advances in

Bioinformatics
Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

Journal of

Marine Biology
Volume 2014

Hindawi Publishing Corporation
http://www.hindawi.com

Volume 2014

